13 found
Order:
Disambiguations
Douglas Wassenaar [8]Douglas R. Wassenaar [3]Douglas Richard Wassenaar [2]
  1.  50
    Mapping African Ethical Review Committee Activity Onto Capacity Needs: The Marc Initiative and Hrweb's Interactive Database of Recs in Africa.Carel Ijsselmuiden, Debbie Marais, Douglas Wassenaar & Boitumelo Mokgatla-Moipolai - 2012 - Developing World Bioethics 12 (2):74-86.
    Health research initiatives worldwide are growing in scope and complexity, particularly as they move into the developing world. Expanding health research activity in low- and middle-income countries has resulted in a commensurate rise in the need for sound ethical review structures and functions in the form of Research Ethics Committees (RECs). Yet these seem to be lagging behind as a result of the enormous challenges facing these countries, including poor resource availability and lack of capacity. There is thus an urgent (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  2.  58
    Improving Understanding of Clinical Trial Procedures Among Low Literacy Populations: An Intervention Within a Microbicide Trial in Malawi. [REVIEW]Paul M. Ndebele, Douglas Wassenaar, Esther Munalula & Francis Masiye - 2012 - BMC Medical Ethics 13 (1):29-.
    Background The intervention reported in this paper was a follow up to an empirical study conducted in Malawi with the aim of assessing trial participants’ understanding of randomisation, double-blinding and placebo use. In the empirical study, the majority of respondents (61.1%; n= 124) obtained low scores (lower than 75%) on understanding of all three concepts under study. Based on these findings, an intervention based on a narrative which included all three concepts and their personal implications was designed. The narrative used (...)
    Direct download (14 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  3.  13
    Defining and Negotiating the Social Value of Research in Public Health Facilities: Perceptions of Stakeholders in a Research‐Active Province of South Africa.Elizabeth Lutge, Catherine Slack & Douglas Wassenaar - 2017 - Bioethics 31 (2):128-135.
    This article reports on qualitative research conducted in KwaZulu-Natal, South Africa, among researchers and gate-keepers of health facilities in the province. Results suggest disparate but not irreconcilable perceptions of the social value of research in provincial health facilities. This study found that researchers tended to emphasize the contribution of research to the generation of knowledge and to the health of future patients while gate-keepers of health facilities tended to emphasize its contribution to the healthcare system and to current patients. Furthermore, (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  20
    Promoting Research Integrity in Africa: An African Voice of Concern on Research Misconduct and the Way Forward.Francis Kombe, Eucharia Nkechinyere Anunobi, Nyanyukweni Pandeni Tshifugula, Douglas Wassenaar, Dimpho Njadingwe, Salim Mwalukore, Jonathan Chinyama, Bodo Randrianasolo, Perpetua Akindeh, Priscilla S. Dlamini, Felasoa Noroseheno Ramiandrisoa & Naina Ranaivo - 2014 - Developing World Bioethics 14 (3):158-166.
    African researchers and their collaborators have been making significant contributions to useful research findings and discoveries in Africa. Despite evidence of scientific misconduct even in heavily regulated research environments, there is little documented information that supports prevalence of research misconduct in Africa. Available literature on research misconduct has focused on the developed world, where credible research integrity systems are already in place. Public attention to research misconduct has lately increased, calling for attention to weaknesses in current research policies and regulatory (...)
    Direct download (9 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  5.  18
    Ethical Issues in Medical Research in the Developing World: A Report on a Meeting Organised by Fondation Mérieux.Christophe Perrey, Douglas Wassenaar, Shawn Gilchrist & Bernard Ivanoff - 2009 - Developing World Bioethics 9 (2):88-96.
  6.  3
    Contextualising the Role of the Gatekeeper in Social Science Research.Shenuka Singh & Douglas Wassenaar - 2016 - South African Journal of Bioethics and Law 9 (1):42-42.
    Accessing research participants within some social institutions for research purposes may involve a simple single administrative event. However, accessing some institutions to conduct research on their data, personnel, clients or service users can be quite complex. Research ethics committee chairpersons frequently field questions from researchers wanting to know when and why gatekeeper permission should be sought. This article examines the role and influence of gatekeepers in formal and organisational settings and explores pragmatic methods to improve understanding and facilitation of this (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  7.  23
    Convergent Ethical Issues in HIV/AIDS, Tuberculosis and Malaria Vaccine Trials in Africa: Report From the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre Consultation, 10-11 February 2009, Durban, South Africa. [REVIEW]Nicole Mamotte, Douglas Wassenaar, Jennifer Koen & Zaynab Essack - 2010 - BMC Medical Ethics 11 (1):3-.
    BackgroundAfrica continues to bear a disproportionate share of the global HIV/AIDS, tuberculosis (TB) and malaria burden. The development and distribution of safe, effective and affordable vaccines is critical to reduce these epidemics. However, conducting HIV/AIDS, TB, and/or malaria vaccine trials simultaneously in developing countries, or in populations affected by all three diseases, is likely to result in numerous ethical challenges.MethodsIn order to explore convergent ethical issues in HIV/AIDS, TB and malaria vaccine trials in Africa, the Ethics, Law and Human Rights (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  6
    The Effect of Relationships on Decision-Making Processes of Women in Harare, Zimbabwe.Nicole Mamotte, Douglas Richard Wassenaar & Aceme Nyika - 2009 - Ethics and Behavior 19 (3):184-200.
    A preliminary study aimed at investigating the potential impact of relationships on decision-making process and autonomy of women was conducted in Harare, Zimbabwe. The majority of women surveyed (87.6%) were prepared to consult their husbands, whereas only 46.6% said they would consult their relatives prior to participation in health research. Only 6.2% and 11.3% were prepared to keep their participation secret from their husbands their relatives, respectively. Overall, 58.6% were rated as autonomous, 22.5% partially autonomous, and 18.9% were rated as (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  9.  7
    Ethical Issues Associated with HIV Phylogenetics in HIV Transmission Dynamics Research: A Review of the Literature Using the Emanuel Framework. [REVIEW]Farirai Mutenherwa, Douglas R. Wassenaar & Tulio de Oliveira - forthcoming - Developing World Bioethics.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  10.  29
    The Global Forum for Bioethics in Research: Past Present and Future.Katherine Littler, Joseph Millum & Douglas Richard Wassenaar - 2014 - South African Journal of Bioethics and Law 7 (1):5.
    The Global Forum on Bioethics in Research (GFBR) served as a global platform for debate on ethical issues in international health research between 1999 and 2008, bringing together research ethics experts, researchers, policy makers and community members from developing and developed countries. In total, nine GFBR meetings were held on six continents. Work is currently underway to revive the GFBR. This paper describes the purpose and history of the GFBR and presents key elements for its reinstatement, future functioning and sustainability. (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  11.  34
    A Developing Country Response to Lavery Et Al.Douglas R. Wassenaar & Gita Ramjee - 2009 - BMC Medical Ethics 10 (1):16.
    A recent paper presents an argument and mechanism for the possible stopping of clinical trials early based on opportunity costs.
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark  
  12.  48
    Payments and Direct Benefits in HIV/AIDS Related Research Projects in Uganda.Julius Ecuru, Douglas Wassenaar & Betty Kwagala - 2010 - Ethics and Behavior 20 (2):95-109.
    Paying research participants in developing countries like Uganda raises ethical concerns over potential for undue inducement. This article, based on an exploratory study, reviewed 49 research protocols from a national HIV/AIDS research ethics committee database. Payments mainly adhered to the reimbursement and compensation payment models. Offers made were diverse but basic in order to limit undue inducement. Implications in terms of undue inducement and possible impact on participants and research are discussed. We end by recommending standardization across comparable studies in (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  13.  7
    A Developing Country Response to Lavery Et Al. "In Global Health Research, is It Legitimate to Stop Clinical Trials Early on Account of Their Opportunity Costs?".Douglas R. Wassenaar & Gita Ramjee - 2009 - BMC Medical Ethics 10 (1):16-.
    BackgroundA recent paper presents an argument and mechanism for the possible stopping of clinical trials early based on opportunity costs.DiscussionAlthough we agree that the costs and opportunity costs of clinical trials need to be reduced wherever possible, we raise concerns about the motivation and mechanism for stopping clinical trials early raised by Lavery et al.SummaryWe argue that there are already enough acceptable criteria and actors in the clinical trials arena to justify early stoppage of clinical trials, and argue that factors (...)
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark